case_images: PMC4775779_01
case_images: CT scan (pretreatment) showing lymph nodes.
case_images: CRIONM2016-2672671.001.jpg
case_images: PMC4775779_01_CRIONM2016-2672671.001.jpg
case_images: fig1
case_images: Unfortunately a CT scan 3 months after his neck dissection showed convincing evidence of metastatic disease with confluent lymphadenopathy in the paratracheal group of nodes, with the target node measuring 22 mm (Figure 1).
case_images: CT showing lung lesion before Vemurafenib.
case_images: CRIONM2016-2672671.002.jpg
case_images: PMC4775779_01_CRIONM2016-2672671.002.jpg
case_images: fig2
case_images: A right lower lobe lung metastasis measuring 26 mm with right perihilar lymph nodes was also noted (Figure 2).
case_images: CT scan showing complete remission.
case_images: CRIONM2016-2672671.003.jpg
case_images: PMC4775779_01_CRIONM2016-2672671.003.jpg
case_images: fig3
case_images: A progress CT scan 2 years after starting treatment showed a complete radiological response; CT scan did not show any pathologically enlarged lymph nodes or any lung metastasis (Figure 3).
case_images: CT scan 12 months after stopping Vemurafenib.
case_images: CRIONM2016-2672671.004.jpg
case_images: PMC4775779_01_CRIONM2016-2672671.004.jpg
case_images: fig4
case_images: Most recent CT scan and clinical evaluation at 12 months after stopping Vemurafenib did not show any radiological or clinical evidence of metastatic melanoma (Figure 4).